Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer
Aurélie Bellanger(Lyon 1 Université), Pascale A. Cohen(Lyon 1 Université), Anne Wierinckx(Lyon 1 Université), Julie A. Vendrell(Inserm), Philippe Clézardin(Université Claude Bernard Lyon 1), Lőrinc Sándor Pongor(National Cancer Institute), Jérôme Solassol(Inserm), Joël Lachuer, Diep T. Le(Lyon 1 Université), Balázs Győrffy(Semmelweis University)
Cited by 8
Related Papers
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
|PLoS ONE|2013|1.9k
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|The Lancet Oncology|2014|410
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
|Endocrine Reviews|2011|302